Clinical Trials Browser

Terminated × INDUSTRY × Uterine Cervical Dysplasia × Clear all

NCT00312286 2016-09-23

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Phase 2 Terminated

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT00117884 2016-08-19

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Phase 2 Terminated

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT01116245 2016-07-27

ADXS11-001

Phase 2 Terminated

Uterine Cervical Dysplasia

NCT00708942 2013-04-24

Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1

Phase 2 Terminated

83 enrolled 14 charts

Uterine Cervical Dysplasia